logo

For the Inventor, By the Inventor

Beijing, China

Beijing Scitech-Mq Pharmaceuticals Limited

USPTO Granted Patents = 8

% Expired Patents = 12.5


Forward Citations = 4

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Qiang Zhang (7 out of 109 patents)

silverMedal Leifu Yang (7 out of 7 patents)

bronzeMedal Shannan Yu (6 out of 6 patents)

4.  Nanqiao Zheng (6 out of 6 patents)

5.  Zhongxiang Wang (4 out of 4 patents)

6.  Shouye Feng (4 out of 4 patents)

7.  Hongbo Zhang (4 out of 11 patents)

8.  Hailong Yang (4 out of 5 patents)

9.  Likai Zhou (4 out of 4 patents)

10.  Zhanqiang Xu (4 out of 4 patents)

11.  Yueming Sun (3 out of 3 patents)

12.  Yansheng Liu (3 out of 4 patents)

13.  Chenming Hu (3 out of 4 patents)

14.  Xingfu Li (2 out of 3 patents)

15.  Shaohua Zhang (1 out of 17 patents)


8 patents:

1. 12582654 - Cyano-substituted pyridine and cyano-substituted pyrimidine compound and preparation method therefor and application thereof (2026-03-24),
2. 12435060 - Acylamino bridged heterocyclic compound, and composition and application thereof (2025-10-07),
3. 12202835 - Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors (2025-01-21),
4. 11548900 - Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof (2023-01-10),
5. 11479559 - Urea-substituted aromatic ring-linked dioxinoquinoline compounds, preparation method and uses thereof (2022-10-25),
6. 11407760 - Dioxinoquinoline compounds, preparation method and uses thereof (2022-08-09),
7. 10980809 - Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof (2021-04-20),
8. 10106508 - Quinazoline heterocyclic compound as EGFR kinase inhibitor and preparation and application thereof (2018-10-23),
Company Overview
Beijing Scitech-mq Pharmaceuticals Limited is a leading pharmaceutical company specializing in the research, development, and production of innovative drug therapies. With a strong focus on biotechnology and precision medicine, the company strives to provide cutting-edge solutions for a wide range of medical conditions. Leveraging its state-of-the-art facilities and a team of experienced scientists, Beijing Scitech-mq Pharmaceuticals is committed to advancing healthcare and improving the quality of life for patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#343 in Beijing

#3,471 in China

Beijing, CN
Beijing, China

Beijing Scitech-Mq Pharmaceuticals Limited

Forward Citations = 4

18 inventors:

goldMedal Qiang Zhang (7 out of 109 patents)

silverMedal Leifu Yang (7 out of 7 patents)

bronzeMedal Shannan Yu (6 out of 6 patents)

4.  Nanqiao Zheng (6 out of 6 patents)

5.  Zhongxiang Wang (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Beijing Scitech-Mq Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/beijing-scitech-mq-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…